FDA
The new article emphasizes the important role of patient preference information.
FDA
The new article pays additional attention to the specific practical considerations pertaining to the use of patient preference information.
FDA
The new article highlights the aspects related to obtaining feedback from the authority in order to ensure compliance with the relevant regulatory requirements.
FDA
The new article is dedicated to additional considerations to be taken into account when using patient preference information associated with medical devices intended to be marketed and used in the US.
FDA
The new article highlights the key points related to the actual implementation of the information collected from patients in the form of feedback.
Austria
The article provides a general overview of the regulatory framework for combination products applicable in the EU in general and in Austria specifically.
